AIMBE Recognition

About

The American Institute for Molecular and Biological Engineering (AIMBE) College of Fellows is comprised of approximately 1,500 individuals who have made significant contributions to the medical and biological engineering community in academia, industry, government, and education.

Over the years, several senior members of ISAC have been granted this prestigious honor.

 

2026

University of Washington

Daniel T. Chiu, PhD

University of Washington

 

2025

Stanford University

Nima Aghaeepour, PhD

Stanford University

University of Virginia

Gustavo Rohde, PhD

University of Virginia

Gene Lay Institute

Gene Lay, DVM

Gene Lay Institute

Waters Corporation

Eric Diebold, PhD

Waters Corporation

 

2024

For pioneering contributions to single cell spectroscopy via innovation in instrumentation and software and international leadership in advancing cytometry

Jessica P. Houston, Ph.D.

New Mexico State University

For pioneering contributions to photon-upconversion materials and innovative photonics technologies for diagnostics

Dayong Jin, Ph.D.

University of Technology Sydney

 

2014

For outstanding contribution to the fundamental innovations in design, function and application of cell sorting technology.

David Parks, Ph.D.

Senior Research Associate at Stanford University

Andreas Radbruch, Sc.D.

Scientific Director, Department of Cell Biology at The German Rheumatism Research Centre Berlin

Scott Tanner, Ph.D.

Chief Technology Officer at Fluidigm

 

2013

For fundamental innovations in the integration of monoclonal antibodies and flow cytometry to study immunology and cell biology.

Noel Warner, Ph.D.

Worldwide Vice President Scientific Affairs, Becton Dickinson Biosciences

For leadership in producing and disseminating medical diagnostic products worldwide and introducing processes for biomedical engineering innovation that serve humanity.

Sue Van

President and Chief CEO of Wallace H. Coulter Foundation

For contributions for determination of standards in surface engineering as well as validation of in vitro systems for drug discovery.

Anne Plant, Ph.D.

Supervisory Research Chemist of the Cell Systems Science at the National Institute of Standards and Technology

For his seminal contributions to the development of drug screening technology and new approaches in the delivery of medicines and novel agents for the treatment of cancer.

Paul J. Smith, Ph.D.

Professor of Cancer Biology, School of Medicine, Cardiff University

 

2012

For outstanding and sustained accomplishments in transforming research oriented cell sorting technologies into viable tools for the biotechnology industry.

Gary Durack

CEO and President of iCyt, a subsidiary of Sony Corporation of America

For outstanding contributions to advanced detection technologies and for his seminal contribution to the design, advancement and manufacture of microfluidic devices.

Masanobu Yamamoto

Life Electronics Division of Sony Corporation of America

 

2011

For pioneering work on polychromatic flow cytometry and its application to understanding immune response to infection.

Larry Sklar, Ph.D.

University of New Mexico School of Medicine

For developing chromosome sorting, bi-variate cell cycle analysis, fluorescence in situ hybridization, competitive genomic hybridization, and cancer specific markers.

Joe Gray, Ph.D.

Lawrence Berkeley National Laboratory

For pioneering work on polychromatic flow cytometry and its application to understanding immune response to infection.

Mario Roederer, Ph.D.

National Institutes of Health

 

2010

For developing and applying techniques to assess the cell cycle, cell kinetics, cellular apoptosis, tumor response and progression.

Zbigniew Darzynkiewicz, Ph.D.

New York Medical College

For inventing and commercializing new capabilities for clinical and research flow cytometers.

Peter Hansen, Ph.D.

Point Care Technologies, Inc.

For executive leadership of cellular analysis and diagnostic system development and translational research worldwide, with widespread benefits to human health.

Elias Caro

Wallace H. Coulter Foundation

 

2009

Leonore A. Herzenberg

Stanford University

For pioneering contributions to the development of inexpensive flow cytometers for developing countries.

Wolfgang Göhde

Partec Corporation

For his valuable contributions to technology and education in the field of complex data analysis for research and clinical flow cytometry.

Bruce Bagwell

Verity Software

 

2008

For outstanding contributions to biotechnology and biomedical research through the development of novel engineered fluorescent probes.

Alan Waggoner, Ph.D.

Carnegie Mellon University

For seminal physics and engineering contributions to the design and application of high speed cell separation and sorting technologies.

Gerrit J. van den Engh, Ph.D.

University of Washington

For the development of fluorescent analog cytochemistry and automated fluorescence microscope systems, and founding the field of high-content screening.

D. Lansing Taylor, Ph.D.

Cellumen, Inc.

Developed two-color flow cytometry techniques leading to multicolor fluorescence instruments for immunophenotyping of leukemias important for new cancer therapies.

Michael Loken, Ph.D.

Hematologics Inc.

Louis A. Kamentsky was the prime mover in the development of flow cytometry, an AIMBE Hall of Fame technology.

Louis Kamentsky, Ph.D.

CompuCyte Corporation

For seminal contributions to the field of analytic cytology, combining immunology, genetics, mathematics and biomedical engineering and for being responsible for bringing the field of flow cytometry to everyday life.

Leonard Herzenberg, Ph.D.

Stanford University Medical School

 

2007

Robert F. Murphy, Ph.D.

Carnegie Mellon University

Development of high-through put cell analysis and rare-event analysis methods/technologies for minimal residual disease monitoring in medicine and combinatorial library screening for drug discovery.

James F. Leary, Ph.D.

Purdue University

For major contribution to the field of Cytometry, for both instrumentation design and assay development that has driven significant change in the field.

Howard Shapiro, M.D.

Shapiro Lab

For contributions to the design, calibration, and application of flow cytometers for research and clinical diagnostics.

Bob Hoffman, Ph.D.

BD Biosciences

 

2006

For contributions in cellular and molecular detection technologies by combination of bioengineering and complex chemistries.

John P. Nolan, Ph.D.

La Jolla Bioengineering Institute

 

2004

J. Paul Robinson, Ph.D.

Purdue University

Log in to access your profile and get your benefits!